PL1755743T3 - Beta-hydroksymaślan i pochodne do leczenia depresji i lęku - Google Patents

Beta-hydroksymaślan i pochodne do leczenia depresji i lęku

Info

Publication number: PL1755743T3
Authority: PL; Poland
Prior art keywords: anxiety; derivatives; treating depression; beta hydroxybutyrate; hydroxybutyrate
Prior art date: 2004-05-12

Application number

PL05742109T

Other languages

English (en)

Inventor

David Greenwood

Wilfried Dimpfel

Original Assignee

Btg Int Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-12

Filing date

2005-05-12

Publication date

2013-08-30

2005-05-12 Application filed by Btg Int Ltd filed Critical Btg Int Ltd

2013-08-30 Publication of PL1755743T3 publication Critical patent/PL1755743T3/pl

Links

WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 title 1
208000019901 Anxiety disease Diseases 0.000 title 1
230000036506 anxiety Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Emergency Medicine (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL05742109T 2004-05-12 2005-05-12 Beta-hydroksymaślan i pochodne do leczenia depresji i lęku PL1755743T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US57013704P	2004-05-12	2004-05-12
GB0420856A GB0420856D0 (en)	2004-09-20	2004-09-20	Cns modulators
PCT/GB2005/001835 WO2005107875A2 (en)	2004-05-12	2005-05-12	Triglycerides, fatty acids, alcohols as cns modulators
EP05742109.1A EP1755743B1 (en)	2004-05-12	2005-05-12	Beta hydroxybutyrate and derivatives for treating depression and anxiety

Publications (1)

Publication Number	Publication Date
PL1755743T3 true PL1755743T3 (pl)	2013-08-30

Family

ID=33306877

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL10184846T PL2316530T3 (pl)	2004-05-12	2005-05-12	Triglicerydy, kwasy tłuszczowe i alkohole jako modulatory oun
PL05742109T PL1755743T3 (pl)	2004-05-12	2005-05-12	Beta-hydroksymaślan i pochodne do leczenia depresji i lęku

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL10184846T PL2316530T3 (pl)	2004-05-12	2005-05-12	Triglicerydy, kwasy tłuszczowe i alkohole jako modulatory oun

Country Status (8)

Country	Link
US (3)	US20080058416A1 (pl)
EP (2)	EP1755743B1 (pl)
DK (2)	DK2316530T3 (pl)
ES (2)	ES2513890T3 (pl)
GB (1)	GB0420856D0 (pl)
PL (2)	PL2316530T3 (pl)
PT (1)	PT1755743E (pl)
WO (1)	WO2005107875A2 (pl)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0427145D0 (en) *	2004-12-10	2005-01-12	Ketocytonyx Inc	Compositions for use in surgery
CA2684213A1 (en)	2007-04-12	2008-10-23	Regents Of The University Of Minnesota	Ischemia/reperfusion protection compositions and methods of using
SG11201506780RA (en)	2013-03-19	2015-10-29	Univ South Florida	Compositions and methods for producing elevated and sustained ketosis
US10568854B2 (en)	2014-05-30	2020-02-25	The Johns Hopkins University	Compositions and methods for treating kabuki syndrome and related disorders
US10980764B1 (en) *	2016-02-01	2021-04-20	University Of South Florida	Exogenous ketone supplements for reducing anxiety-related behavior
US11103470B2 (en)	2017-11-22	2021-08-31	Axcess Global Sciences, Llc	Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11185518B2 (en)	2017-12-19	2021-11-30	Axcess Global Sciences, Llc	S-beta-hydroxybutyrate compounds and compositions enriched with S-enantiomer
US10973786B2 (en)	2016-03-11	2021-04-13	Axcess Global Sciences, Llc	R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, and RS-beta-hydroxybutyrate mixed salt compositions
US10736861B2 (en)	2016-03-11	2020-08-11	Axcess Global Sciences, Llc	Mixed salt compositions for producing elevated and sustained ketosis
US11241403B2 (en)	2016-03-11	2022-02-08	Axcess Global Sciences, Llc	Beta-hydroxybutyrate mixed salt compositions and methods of use
US10973792B2 (en)	2019-02-13	2021-04-13	Axcess Global Sciences, Llc	Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use
WO2017184788A1 (en) *	2016-04-19	2017-10-26	Keto Patent Group, Inc.	Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans
US10925843B2 (en)	2018-04-18	2021-02-23	Axcess Global Sciences, Llc	Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US12329734B2 (en)	2017-12-19	2025-06-17	Axcess Global Sciences, Llc	Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow
US11026929B2 (en)	2016-04-19	2021-06-08	Keto Patent Group, Inc.	Administration of berberine metabolites
US11202769B2 (en)	2017-11-22	2021-12-21	Axcess Global Sciences, Llc	Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
US12496283B2 (en)	2016-04-19	2025-12-16	Axcess Global Sciences, Llc	Administration of R-beta-hydroxybutyrate and related compounds in humans
US11806324B2 (en)	2018-04-18	2023-11-07	Axcess Global Sciences, Llc	Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
US20230346721A1 (en)	2018-04-18	2023-11-02	Axcess Global Sciences, Llc	Beta-hydroxybutyric acid compositions and methods for delivery of ketone bodies
US12533346B2 (en)	2016-04-19	2026-01-27	Axcess Global Sciences, Llc	Administration of berberine metabolites
US11944598B2 (en)	2017-12-19	2024-04-02	Axcess Global Sciences, Llc	Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
US12109182B2 (en)	2016-04-19	2024-10-08	Axcess Global Sciences, Llc	Administration of R-beta-hydroxybutyrate and related compounds in humans
US12521378B2 (en)	2016-04-19	2026-01-13	Axcess Global Sciences, Llc	Administration of R-beta-hydroxybutyrate salt blend and related compounds in humans
WO2018009208A1 (en) *	2016-07-08	2018-01-11	Cognate Nutritionals, Inc.	Nutritional mitiggation of the cns effects of traumatic brain injury
US20180057846A1 (en)	2016-08-30	2018-03-01	KetoneAid Inc.	Partially buffered free acid and/or ketone blend for rapid onset ketosis and metabolic therapy
US10307398B2 (en)	2016-09-20	2019-06-04	Regents Of The University Of Minnesota	Resuscitation composition and methods of making and using
WO2018081118A1 (en)	2016-10-24	2018-05-03	University Of South Florida	Delaying latency to seizure by combinations of ketone supplements
US20180177753A1 (en) *	2016-12-23	2018-06-28	Neuroenergy Ventures, Inc.	Glyceryl 3-hydroxybutyrates for migraine symptom management
US9925164B1 (en)	2017-01-12	2018-03-27	Neuroenergy Ventures, Inc.	Glyceryl 3-hydroxybutyrates for traumatic brain injury
US10376528B2 (en)	2017-03-10	2019-08-13	Tecton Group, Llc	Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor
US12171735B2 (en)	2017-04-19	2024-12-24	Axcess Global Sciences, Llc	Administration of butyrate, beta-hydroxybutyrate, cannabidiol, and related compounds in humans
US11760963B2 (en)	2017-08-23	2023-09-19	KetoneAid Inc.	Ketogenic beer and alcoholic beverage mixture containing non-racemic ethyl 3-hydroxybutyrate and/or 1,3 butanediol
US12090129B2 (en)	2017-11-22	2024-09-17	Axcess Global Sciences, Llc	Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11129802B2 (en)	2018-08-27	2021-09-28	Axcess Global Sciences, Llc	Compositions and methods for delivering cannabidiol and ketone bodies
US11419836B2 (en)	2019-02-13	2022-08-23	Axcess Global Sciences, Llc	Racemic and near racemic beta-hydroxybutyrate mixed salt-acid compositions
US11241401B2 (en)	2020-02-06	2022-02-08	Axcess Global Sciences, Llc	Enantiomerically pure r-beta-hydroxybutyrate mixed salt-acid compositions
US10980772B2 (en)	2018-08-27	2021-04-20	Axcess Global Sciences, Llc	Compositions and methods for delivering tetrahydrocannabinol and ketone bodies
US20200061023A1 (en) *	2018-08-27	2020-02-27	Axcess Global Sciences, Llc	Compositions and methods for delivering tetrahydrocannabinol and ketone bodies
US12472200B2 (en)	2019-05-15	2025-11-18	Axcess Global Sciences, Llc	Autobiotic compositions and method for promoting healthy gut microbiome
PL3976021T3 (pl)	2019-05-30	2025-07-21	Neuroenergy Ventures, Inc.	Tri(beta-hydroksymaślan) glicerolu do zastosowania w leczeniu i zapobieganiu przemijającym atakom niedokrwiennym neuronów
US11969430B1 (en)	2023-03-10	2024-04-30	Axcess Global Sciences, Llc	Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance
US11033553B2 (en)	2019-06-21	2021-06-15	Axcess Global Sciences, Llc	Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11950616B2 (en)	2019-06-21	2024-04-09	Axcess Global Sciences, Llc	Non-vasoconstricting energy-promoting compositions containing ketone bodies
US12167993B2 (en)	2019-06-21	2024-12-17	Axcess Global Sciences, Llc	Non-vasoconstricting energy-promoting compositions containing ketone bodies
US12396974B2 (en)	2020-03-27	2025-08-26	KetoneAid	Ketone ester as a therapeutic treatment of Covid-19 and related viral infections
US12186297B2 (en)	2020-08-26	2025-01-07	Axcess Global Sciences, Llc	Compositions and methods for increasing lean-to-fat mass ratio
TWI804037B (zh)	2021-11-02	2023-06-01	長庚醫療財團法人高雄長庚紀念醫院	生酮飲食之評估系統及其運作方法

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE637726A (pl) *	1962-09-26
GB1476624A (en) *	1973-05-30	1977-06-16	Cepbepe	Tranquiliser medicaments
US4363815A (en) *	1975-07-23	1982-12-14	Yu Ruey J	Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
DE2733202A1 (de) *	1976-08-04	1978-02-09	Agroferm Ag	Verfahren zur herstellung der d(-)-3-hydroxybuttersaeure
US4067999A (en) *	1976-12-15	1978-01-10	Food Technology Products	Control of hemorrhagic enteritis in turkeys
US4234599A (en) *	1978-10-04	1980-11-18	Scott Eugene J Van	Treatment of skin keratoses with α-hydroxy acids and related compounds
US4346107A (en) *	1979-02-12	1982-08-24	Claudio Cavazza	Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism
US4351835A (en) *	1981-04-01	1982-09-28	Montefiore Hospital	Method for preventing body fat deposition in mammals
FR2521857B1 (fr) *	1982-02-23	1985-10-31	Solvay	Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee
DE3229955A1 (de) *	1982-08-12	1984-02-16	Erichsen, Friedrich Karl, Dr., 2351 Schillsdorf	Arzneimittel mit analgetischer wirkung
US4701443A (en) *	1983-03-22	1987-10-20	Baxter Travenol Laboratories, Inc.	Nutrient polyesters
EP0215138B1 (fr) *	1985-09-06	1991-01-16	Societe Des Produits Nestle S.A.	Préservation des tissus vivants
GB8525666D0 (en) *	1985-10-17	1985-11-20	Ici Plc	Chemical process
AU6776887A (en) *	1985-12-18	1987-07-15	Veech, R.L.	Fluid therapy with l-lactate and/or pyruvate anions
US5719119A (en) *	1985-12-18	1998-02-17	British Technology Group, Ltd.	Parenteral nutrition therapy with amino acids
WO1987003809A1 (en) *	1985-12-20	1987-07-02	Veech Richard L	Preparation of electrolyte solutions and containers
US5126373A (en) *	1987-11-19	1992-06-30	Henri Brunengraber	Composition for parenteral and oral nutrition
US4997976A (en) *	1988-11-15	1991-03-05	Henri Brunengraber	Use of 1,3-butanediol acetoacetate in parenteral oral nutrition
US5292774A (en) *	1988-07-26	1994-03-08	Kanegafuchi Kagaku Kogyo Kabushiki Kaisha	Substitution fluid preparation comprising 3-hydroxy-butyric acid (β-hydroxybutric acid) and its salts
US5116868A (en) *	1989-05-03	1992-05-26	The Johns Hopkins University	Effective ophthalmic irrigation solution
US5286842A (en) *	1991-07-01	1994-02-15	Mitsubishi Kasei Corporation	Process for producing a biodegradable polymer
US5654266A (en) *	1992-02-10	1997-08-05	Chen; Chung-Ho	Composition for tissues to sustain viability and biological functions in surgery and storage
US5348979A (en) *	1992-12-23	1994-09-20	Iowa State University Research Foundation Inc.	Method of promoting nitrogen retention in humans
WO1995009144A1 (en) *	1993-09-30	1995-04-06	Eastman Chemical Company	Nutritive water soluble glycerol esters of hydroxy butyric acid
US5912269A (en) *	1996-04-30	1999-06-15	Vertex Pharmaceuticals, Inc.	Butyrate prodrugs derived from lactic acid
JP4598203B2 (ja) *	1995-12-01	2010-12-15	ビーティージー・インターナショナル・リミテッド	脳機能改善剤
JPH10158166A (ja) *	1996-12-02	1998-06-16	Taisho Pharmaceut Co Ltd	貼付剤
ES2530753T3 (es) *	1997-03-17	2015-03-05	Btg Int Ltd	Composiciones terapéuticas que comprenden cuerpos cetónicos y precursores de los mismos
US6323237B1 (en) *	1997-03-17	2001-11-27	Btg International Limited	Therapeutic compositions
US6207217B1 (en) *	1998-01-07	2001-03-27	Pioneer Hi-Bred International, Inc.	Animal nutrition compositions
US6077867A (en) *	1998-01-21	2000-06-20	Fideline	Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
CA2338090C (en) *	1998-07-22	2009-07-14	Metabolix, Inc.	Nutritional and therapeutic compositions of 3-hydroxyacids for increasing blood ketone bodies
KR100805490B1 (ko) *	1998-09-15	2008-02-20	비티지 인터내셔널 리미티드	치료 조성물 （ⅱ）
US6835750B1 (en) *	2000-05-01	2004-12-28	Accera, Inc.	Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
ES2323940T3 (es) *	2000-05-01	2009-07-28	Accera, Inc.	Uso de trigliceridos de cadena media para el tratamiento y prevencion de la enfermedad de alzheimer.
AU2002229452A1 (en) *	2001-02-07	2002-08-19	W. Mcintyre Burnham	Method of treating neurological disorders using acetone derivatives
US20020132846A1 (en) *	2001-02-26	2002-09-19	Caleb Stone	Use of gamma substituted gamma-butyrolactones to increase levels of their corresponding substituted gamma-hydroxybutyrate derivatives in humans
WO2002102363A1 (en) *	2001-06-20	2002-12-27	Lorus Therapeutics Inc.	Biological response modifier composition and uses thereof
US6579543B1 (en) *	2002-02-22	2003-06-17	Jackie H. McClung	Composition for topical application to skin
JP2003306430A (ja) *	2002-04-16	2003-10-28	Lion Corp	皮膚外用剤組成物
DK1648952T3 (en) *	2003-06-03	2018-05-28	The Us Gov As Represented By The Department Of Health And Human Services	Dietary supplements and therapeutic compositions comprising (R) -3-hydroxybutyrate derivatives
WO2005034874A2 (en) *	2003-10-08	2005-04-21	The Mclean Hospital Corporation	Enhanced efficacy of omega-3 fatty acid therapy in the treatment of psychiatric disorders and other indications
EP1727554A4 (en) *	2003-10-08	2009-09-30	Mclean Hospital Corp	METHODS OF TREATING PSYCHIATRIC DISORDERS, ALCOHOL AND DRUG ABUSE DISORDERS, AND OTHER DISORDERS USING COMBINATIONS CONTAINING OMEGA 3 FATTY ACIDS

2004
- 2004-09-20 GB GB0420856A patent/GB0420856D0/en not_active Ceased
2005
- 2005-05-12 PL PL10184846T patent/PL2316530T3/pl unknown
- 2005-05-12 ES ES10184846.3T patent/ES2513890T3/es not_active Expired - Lifetime
- 2005-05-12 DK DK10184846.3T patent/DK2316530T3/da active
- 2005-05-12 DK DK05742109.1T patent/DK1755743T3/da active
- 2005-05-12 ES ES05742109T patent/ES2410588T3/es not_active Expired - Lifetime
- 2005-05-12 US US11/596,012 patent/US20080058416A1/en not_active Abandoned
- 2005-05-12 PL PL05742109T patent/PL1755743T3/pl unknown
- 2005-05-12 PT PT57421091T patent/PT1755743E/pt unknown
- 2005-05-12 EP EP05742109.1A patent/EP1755743B1/en not_active Expired - Lifetime
- 2005-05-12 EP EP10184846.3A patent/EP2316530B1/en not_active Expired - Lifetime
- 2005-05-12 WO PCT/GB2005/001835 patent/WO2005107875A2/en not_active Ceased
2014
- 2014-06-17 US US14/307,231 patent/US20140296337A1/en not_active Abandoned
2021
- 2021-12-08 US US17/643,237 patent/US20220202760A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PT1755743E (pt)	2013-06-03
EP2316530A1 (en)	2011-05-04
EP2316530B1 (en)	2014-08-13
US20140296337A1 (en)	2014-10-02
DK1755743T3 (da)	2013-06-10
ES2513890T3 (es)	2014-10-27
DK2316530T3 (da)	2014-11-03
US20220202760A1 (en)	2022-06-30
US20080058416A1 (en)	2008-03-06
PL2316530T3 (pl)	2015-01-30
ES2410588T3 (es)	2013-07-02
GB0420856D0 (en)	2004-10-20
WO2005107875A2 (en)	2005-11-17
WO2005107875A3 (en)	2006-03-23
EP1755743B1 (en)	2013-04-24
EP1755743A2 (en)	2007-02-28

Publication	Publication Date	Title
PL1755743T3 (pl)	2013-08-30	Beta-hydroksymaślan i pochodne do leczenia depresji i lęku
SG118318A1 (en)	2006-01-27	Smooth outer coating for combustor components and coating method therefor
IL185280A0 (en)	2008-02-09	Tetrahydroindolone and tetrahydroindazolone derivatives
ZA200606734B (en)	2008-01-08	Thiazole derivative
IL177793A0 (en)	2006-12-31	Method and composition for burned skin
IL182380A0 (en)	2007-07-24	Unified analog input front end apparatus and method
TWI351224B (en)	2011-10-21	Cursor controlling method and apparatus using the same
ZA200703884B (en)	2009-07-29	S-mirtazapine for the treatment of hot flush
EP2077262A4 (en)	2011-12-28	IMINOPYRIDINE DERIVATIVE AND USE THEREOF
GB2418618B (en)	2009-08-05	Tracheostomy apparatus
PL1908779T3 (pl)	2013-06-28	Pochodne tymozyny beta 4 i ich zastosowanie
GB2411985B (en)	2007-08-29	Bus arrangement and method thereof
EP1797276A4 (en)	2012-10-10	SLEEVE ARRANGEMENT
IL199427A (en)	2017-03-30	Radiation-protective compounds and related methods
IL178888A0 (en)	2007-03-08	Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
EP1757996A4 (en)	2010-01-20	HEATING FOR FASTENING AND METHOD OF MANUFACTURING
GB0521013D0 (en)	2005-11-23	Combustor and component for combustor
GB0423746D0 (en)	2004-11-24	Process and polymorphs prepared thereby
IL195920A0 (en)	2009-09-01	3-(1h-indol-3-ydindan-1-ylamine derivatives for the treatment of depression and anxiety
GB2410745B (en)	2007-07-25	Cholestanyl derivatives
EP1810976A4 (en)	2007-10-17	BENZONAPHTHACENEGLYCOSIDE DERIVATIVE AND THE USE THEREOF
IL177105A0 (en)	2006-12-10	Coumarin derivative and use thereof
IL243648A0 (en)	2016-02-29	A method for administering beta interferon
GB2420164B (en)	2006-07-19	Supply Mounting Apparatus and Method for Construction
GB0604711D0 (en)	2006-04-19	Architrave Support And Architrave Relating Thereto